Wellington Management Group
EDIT icon

Wellington Management Group’s Editas Medicine EDIT Stock Holding History

Wellington Management Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
+309,395
New +$904K ﹤0.01% 1747
2025
Q4 		– Sell
-295,257
Closed -$1.02M – 1960
2025
Q3 		$1.02M Buy
+295,257
New +$824K ﹤0.01% 1772
2020
Q1 		– Sell
-22,299
Closed -$660K – 1947
2019
Q4 		$660K Buy
+22,299
New +$557K ﹤0.01% 1804
2019
Q3 		– Sell
-37,244
Closed -$922K – 2035
2019
Q2 		$922K Buy
37,244
+25,531
+218% +$609K ﹤0.01% 1786
2019
Q1 		$286K Buy
+11,713
New +$265K ﹤0.01% 1967
2018
Q4 		– Sell
-9,859
Closed -$314K – 2087
2018
Q3 		$314K Sell
9,859
-157,526
-94% -$5.09M ﹤0.01% 2125
2018
Q2 		$6M Sell
167,385
-17,912
-10% -$634K ﹤0.01% 1434
2018
Q1 		$6.14M Buy
185,297
+148,282
+401% +$5.28M ﹤0.01% 1416
2017
Q4 		$1.14M Sell
37,015
-5,594
-13% -$141K ﹤0.01% 1871
2017
Q3 		$1.02M Buy
+42,609
New +$811K ﹤0.01% 1876

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Wellington Management Group's EDIT Position: Q2 2026 in Review

Wellington Management Group opened a new position in Editas Medicine (EDIT) in Q2 2026: 309,395 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #1747 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in EDIT as recently as Q3 2025.

Wellington Management Group first reported a position in EDIT in Q3 2017 and has held it in 10 quarters since. The position peaked at $6.14M in Q1 2018. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Wellington Management Group held 309,395 shares of Editas Medicine worth $1M as of Q2 2026.
  • Editas Medicine was a new Wellington Management Group position in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1747 holding.
  • Wellington Management Group first reported a position in Editas Medicine in Q3 2017 and has held it in 10 quarters since.
  • Wellington Management Group's Editas Medicine position peaked at $6.14M in Q1 2018.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.